Dosage Form Development
ARTICLES
-
GPEx® Lightning: Stable Cell Line Development For Complex Biologics
GPEx® Lightning delivers stable cell pools in 25 days, titers exceeding 15g/L for mAbs and 11g/L for bispecifics, and 60+ generations of stability — compressing timelines by 6–12 weeks.
-
ADCs Are Reshaping Cancer Treatment
The future of ADCs depends on more than breakthrough science. Learn what sponsors now expect from CDMOs to accelerate development, reduce risk, and support commercial success.
SUPPLIER PROFILES
-
Haupt Pharma AG
With nine sites in Germany, Italy, France and Japan, and a representative office in the U.S., Haupt Pharma is one of the largest European companies for pharmaceutical contract development and manufacturing.
-
Kemwell Biopharma
With manufacturing locations in Bangalore India, and Uppsala Sweden, Kemwell offers the entire value chain from early & late stage drug development services, clinical trial supply support, to commercial contract drug manufacturing.
-
Paragon BioServices, Inc.
Founded in 1990, Paragon Bioservices is a CMC Center of Excellence delivering research, development and cGMP manufacturing services to pharmaceutical companies, biotechnology companies and federal agencies
-
Aesica Pharmaceuticals
Aesica Pharmaceuticals is committed to being one of the world’s leading contract developers and manufacturers of pharmaceuticals.
-
UPM Pharmaceuticals, Inc.
UPM Pharmaceuticals, Inc. is a Baltimore-based, independent drug development and contract manufacturer serving the pharmaceutical and biotechnology industries.
SUPPLIERS
SERVICES
-
Leveraging Transformational Formulation Technologies: LNPs
Increasingly we are seeing customers that are looking for specialized formulation capabilities and, specifically, expertise in developing lipid nanoparticles. August Bio can work with a range of LNP formulation and sizing technologies to achieve the desired product profile.
-
Your Top Partner For Ophthalmic Drug Development
As a leading partner in ocular therapy, Altasciences is at the forefront of ophthalmic drug development. Our integrated CRO/CDMO solutions can support your program from lead candidate selection to market. You will benefit from working with a single partner as your product advances through each phase of drug development—from prototype formulation through preclinical testing, to early phase clinical trials, and manufacturing. This could mean up to 40% in time savings.
NEWS
- AGC Biologics Launches BravoAAV™ And ProntoLVV™ Platforms
- Northway Biotech Enters Into Partnership Agreement With Revolo Biotherapeutics To Manufacture Revolo Biotherapeutics' Novel Binding Immunoglobulin Protein '1805
- Nanoform's Final Clinical Results Confirm Value Proposition To The Pharma Industry